2007
DOI: 10.1021/ol0701013
|View full text |Cite
|
Sign up to set email alerts
|

Enantioselective Total Synthesis of Macrolide Antitumor Agent (−)-Lasonolide A

Abstract: [structure: see text] An enantioselective total synthesis of (-)-lasonolide A is described. The upper tetrahydropyran ring was constructed stereoselectively by an intramolecular 1,3-dipolar cycloaddition reaction. The bicyclic isooxazoline led to the tetrahydropyran ring as well as the quaternary stereocenter present in the molecule. The lower tetrahydropyran ring was assembled by a catalytic asymmetric hetero-Diels-Alder reaction as the key step. Three stereocenters were enantioselectively installed in this s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
35
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 52 publications
(35 citation statements)
references
References 32 publications
0
35
0
Order By: Relevance
“…Macrolactone 139 was prepared by intramolecular Horner-Emmons reaction. This was converted to lasonolide A ( 22 ) 29. Using synthetic lasonolide A, we have investigated the biological mechanism of action in collaboration with Dr. Yves Pommier of the National Cancer Institute.…”
Section: Introductionmentioning
confidence: 99%
“…Macrolactone 139 was prepared by intramolecular Horner-Emmons reaction. This was converted to lasonolide A ( 22 ) 29. Using synthetic lasonolide A, we have investigated the biological mechanism of action in collaboration with Dr. Yves Pommier of the National Cancer Institute.…”
Section: Introductionmentioning
confidence: 99%
“…12 DIBAL-H reduction of ester 4 provided aldehyde 5, which was condensed with nitrobutane to afford nitroalkene 6 using a two-step procedure. 13 Zinc-mediated reduction 14 afforded the oxime 7, and subsequent NaCNBH 3 reduction 8b afforded a 1:1 inseparable mixture 1a and 1b). Importantly, the lack of stereocontrol at C2 resulting from this reduction offered the opportunity to study the cyclization of both epimers.…”
Section: Methodsmentioning
confidence: 99%
“…This endeavor resulted in the total synthesis of numerous targets, covering over two dozen or so different structural families. Some notable examples of our accomplished bioactive targets include novel and exceedingly potent microtubule stabilizing agents, laulimalide ( 1 )4 and peloruside A ( 2 )5 a potent microtubule destabilizing agent cryptophycin 52 ( 3 )6; anticancer agents amphidinolide T ( 4 )7, amphidinolide W ( 5 )8, and lasonolide A ( 6 )9; antibiotic agent, madumycin II ( 7 )10; pancreatic lipase inhibitor, tetrahydrolipstatin ( 8 )11; novel actin inhibitory agents doliculide ( 9 )12 and jasplakinolide ( 10 )13; novel antibacterial agent platensimycin ( 11 )14; and the histone deacytelase inhibitor, largazole ( 12 )15 (see Figure 1). The unique structural features of these natural products required the development of new synthetic tools and methodologies for their synthesis.…”
Section: Introductionmentioning
confidence: 99%